Jonathan Williams-Primary Hyperaldosteronism From A to Z
Watch this webinar on LabRoots at http://www.labroots.com/webinar/primary-hyperaldosteronism
The prevalence of primary hyperaldosteronism among general and resistant hypertensive populations ranges from 5-20%. It is considered a secondary form of hypertension caused by inappropriate secretion of aldosterone and activation of the mineralocorticoid receptor. As such, it is a highly treatable and potentially curable form of hypertension. This webinar will review the prevalence, pathophysiology, screening and diagnostic studies, and treatment options for patients with primary hyperaldosteronism so that the Practitioner can accurately screen and identify cases.
Видео Jonathan Williams-Primary Hyperaldosteronism From A to Z канала Labroots
The prevalence of primary hyperaldosteronism among general and resistant hypertensive populations ranges from 5-20%. It is considered a secondary form of hypertension caused by inappropriate secretion of aldosterone and activation of the mineralocorticoid receptor. As such, it is a highly treatable and potentially curable form of hypertension. This webinar will review the prevalence, pathophysiology, screening and diagnostic studies, and treatment options for patients with primary hyperaldosteronism so that the Practitioner can accurately screen and identify cases.
Видео Jonathan Williams-Primary Hyperaldosteronism From A to Z канала Labroots
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Aldosteronism Screening and DiagnosisEndocrine | Hyperaldosteronism for NCLEXHyperaldosteronism - causes, symptoms, diagnosis, treatment, pathologyPrimary AldosteronismAldosterone, Hypertension, & Antihypertensive TherapyFrom start up to scale up: Creative solutions to modernize your lab budgetHormóny, Peter RačayHyponatremia: Causes: Adrenal insufficiencyAdrenal Gland (Adrenal Cortex) Explained ClearlyRecent Advances and Challenges in the Diagnosis and Management of Cushing's DiseaseUpdates on Primary Aldosteronism Screening and Use of Direct ReninThe growing concern of off-target effects: How to measure and minimize off-target effects...Hyperaldosteronism and Conn's SyndromeStudy design: How and when to use multiplexed immunofluorescence imaging in your researchHyperaldosteronismHypokalemia: Causes: AlkalosisNew fixable viability dyes and applications for flow cytometryThe Evolution of the Primary Aldosteronism SyndromeAlison Woodworth and Joesph Wiencek - Advances in the Diagnosis of Primary AldosteronismMultiple sclerosis - causes, symptoms, diagnosis, treatment, pathology